Potent and selective bradykinin B2
receptor antagonist (pA2
= 9.04). Also inhibits aminopeptidase N (Ki
= 9.1 μ
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies.
Hock et al.
Agonistic and antagonistic properties of the bradykinin B2 receptor antagonist, Hoe 140, in isolated blood vessels from different species.
Feletou et al.
The bradykinin B2 receptor antagonist icatibant (Hoe 140) blocks aminopeptidase N at micromolar concentrations: off-target alterations of signaling mediated by the bradykinin B1 and angiotensin receptors.
Bawolak et al.
The citations listed below are publications that use Tocris products. Selected citations for HOE 140 include:
Showing Results 1 - 1 of 1